GameStop closes out September at $23.76, down 1% on the week, and the question that matters is increasingly simple: Ryan Cohen has spent roughly $59 million buying shares in the open market over the past 90 days, and the stock is going nowhere.
That stalemate defines the current setup. Cohen's September 29 purchase, 450,000 shares at $23.48 for a $10.6 million outlay, is his tenth activist 13D/A filing since April 2025. The filing confirms his stake at 8.8% of shares outstanding. Director Alain Attal added 17,500 shares on September 21. None of these purchases were made under pre-arranged 10b5-1 plans. These are discretionary bets, placed in public, at progressively higher prices than August. The 90-day net buying across the insider group totals $58.7 million in value. For most stocks, that cluster would be a headline catalyst. For GME this month, it produced a brief lift on the filing date and no lasting follow-through.
Short interest tells the other side of the story. Bears have rebuilt their position through September without folding. Short interest ended the week at 6.9% of the free float, roughly 31 million shares, down 6.6% on the week and more than 53% below its August peak of around 66 million shares. That peak coincided with the stock's weakness before the first big Cohen buy came in. The current level is not extreme, but it is not trivial either. Borrow availability is loose at 271%, meaning roughly 200 million shares remain available in the lending pool, so fresh shorts face no meaningful friction entering positions. Cost to borrow is negligible at 0.41%, less than half its August level, confirming there is no squeeze pressure in the lending market. The ORTEX short score sits at 55.2, roughly mid-range, consistent with a moderately elevated but not crowded short book.
Options traders are skewing firmly bullish, which adds another layer of tension. The put/call ratio is at 0.26, near the bottom of its 52-week range of 0.24 to 0.81, and marginally below the 20-day average of 0.27. Call open interest is running well ahead of puts. That positioning reflects the meme-stock community's continued appetite for upside exposure, but with the PCR this close to a 52-week low, there is limited room for options sentiment to get more bullish from here.
The fundamental picture remains challenged. Analyst coverage is thin and stale; the most recent action on record is a Wedbush Underperform reiteration from June 2025 at a $13.50 target, well below the current price, though that data is now over a year old. The bull case rests on collectibles revenue growing 54.6% year-over-year and an improved gross margin of 34.5%, supported by the $1.5 billion convertible note raise. Against that, hardware sales fell 31.7% and software declined 26.7%, and the store estate continues to shrink. Valuation multiples are effectively unmeasurable given negative earnings. Wikipedia attention for the stock is running 1.8 standard deviations below its own 90-day average, a signal that retail engagement has cooled relative to the August frenzy.
The dynamic heading into December 8 earnings is one of attrition. Cohen is buying, the short book is holding, and price is compressing into a narrower range. The next print will test whether the margin improvement story has legs, or whether the revenue trajectory continues to deteriorate faster than the cost structure can absorb.
See the live data behind this article on ORTEX.
Open GME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
